Save

The impact of probiotics and n-3 long-chain polyunsaturated fatty acids on intestinal permeability in pregnancy: a randomised clinical trial

in Beneficial Microbes
Autor:innen:
K. Mokkala Institute of Biomedicine, University of Turku, 20014 Turku, Finland.

Search for other papers by K. Mokkala in
Current site
Google Scholar
PubMed
Close
,
P. Pussinen Oral and Maxillofacial Diseases, University of Helsinki and University Hospital of Helsinki, 00014 Helsinki, Finland.

Search for other papers by P. Pussinen in
Current site
Google Scholar
PubMed
Close
,
N. Houttu Institute of Biomedicine, University of Turku, 20014 Turku, Finland.

Search for other papers by N. Houttu in
Current site
Google Scholar
PubMed
Close
,
E. Koivuniemi Institute of Biomedicine, University of Turku, 20014 Turku, Finland.
Turku University Hospital, Department of Obstetrics and Gynaecology, 20014 Turku, Finland.

Search for other papers by E. Koivuniemi in
Current site
Google Scholar
PubMed
Close
,
T. Vahlberg Department of Clinical Medicine, Biostatistics, University of Turku and Turku University Hospital, 20014 Turku, Finland.

Search for other papers by T. Vahlberg in
Current site
Google Scholar
PubMed
Close
, und
K. Laitinen Institute of Biomedicine, University of Turku, 20014 Turku, Finland.

Search for other papers by K. Laitinen in
Current site
Google Scholar
PubMed
Close
Zitierung herunterladen Berechtigungen erhalten

Optionen für den Zugriff

Nutzen Sie bitte eine der untenstehenden Zugriffsmöglichkeiten, um den vollständigen Artikel zu lesen.

Institutszugang

Melden Sie sich mit Open Athens, Shibboleth oder Ihren institutionellen Anmeldedaten an.

Über Institut einloggen

Kauf

Sofortzugang erwerben (PDF-Download und unbegrenzter Online-Zugang):

36,93 €

Weitere Zugriffsmöglichkeiten

Auf DeepDyve mieten
Token einlösen

A disruption in intestinal barrier integrity may predispose individuals to metabolic aberrations, particularly during the vulnerable period of pregnancy. We investigated whether intestinal permeability, as measured by serum zonulin concentration, changes over the duration of pregnancy and whether this change is reflected in lipopolysaccharide (LPS) activity. Second, we tested in a randomised double-blind placebo controlled clinical trial the impact of consuming dietary probiotics and/or long chain polyunsaturated fatty acid (LC-PUFA) supplements in lowering serum zonulin concentration and LPS activity. The probiotic supplement was a combination of two bacteria, Bifidobacterium animalis ssp. lactis 420 and Lactobacillus rhamnosus HN001. This study included 200 overweight pregnant women participating in an on-going study; participants were randomised to consume either (1) probiotics, (2) LC-PUFA, (3) probiotics and LC-PUFA, or (4) placebo for each supplement. Blood samples were obtained at early, the baseline, and late pregnancy (mean 14 and 35 weeks of gestation, respectively). Serum zonulin concentration increased from early (mean (standard deviation): 62.7 (12.9) ng/ml) to late pregnancy by 5.3 (95%CI 3.7-6.9) ng/ml, and LPS activity increased from (0.16 (0.04) EU/ml) by 0.04 (95%CI 0.03-0.05) EU/ml. No differences among the intervention groups were detected in the change from early to late pregnancy in serum zonulin concentration (P=0.8) or LPS activity (P=0.2). The change in serum zonulin concentration during the pregnancy was associated with the weeks of follow up (r=0.25, P<0.001). Serum LPS activity was correlated with higher maternal weight gain (r=0.19, P=0.008). As a conclusion, intestinal permeability increased with the progression of pregnancy in overweight and obese women and was reflected in LPS activity. No efficacy of supplementation with probiotics and/or LC-PUFA was demonstrated in pregnancy-induced changes in serum zonulin concentration or LPS activity.

Kennzahlen

Insgesamt Letzte 365 Tage In den letzten 30 Tagen
Aufrufe von Kurzbeschreibungen 1021 371 59
Gesamttextansichten 28 4 0
PDF-Downloads 48 12 0